ARCA Biopharma Trades Over 13% Lower as Company States "substantial doubt exists as to our ability to continue as a going concern" in a 10-Q Filing Last Night

Full paragraph from the 10-Q Filing "Our management and our independent registered public accountant, in their report on our financial statements as of and for the year ended December 31, 2010, have concluded that due to our need for additional capital, and the uncertainties surrounding our ability to raise such funding, substantial doubt exists as to our ability to continue as a going concern."